Weiss Multi-Strategy Advisers’s Novavax NVAX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,000	Closed	-$119K	–	493
2014 Q4	$119K	Hold	1,000	–	–	﹤0.01%	391
2014 Q3	$83K	Hold	1,000	–	–	﹤0.01%	509
2014 Q2	$92K	Sell	1,000 -2,259	-69%	-$199K	﹤0.01%	702
2014 Q1	$295K	Buy	3,259 +1,259	+63%	+$141K	0.01%	831
2013 Q4	$205K	Sell	2,000 -500	-20%	-$35.3K	﹤0.01%	903
2013 Q3	$158K	Buy	+2,500	New	+$141K	﹤0.01%	876

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NVAX Position: Q1 2015 in Review

Weiss Multi-Strategy Advisers sold out of Novavax (NVAX) in Q1 2015, closing a stake of 1,000 shares — an estimated $119K sold.

Weiss Multi-Strategy Advisers first reported a position in NVAX in Q3 2013 and held it in 6 quarters. The position peaked at $295K in Q1 2014. 167 funds tracked by Wall St. Rank hold NVAX as of Q1 2015.

Weiss Multi-Strategy Advisers reported no remaining Novavax position as of Q1 2015 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 1,000 Novavax shares in Q1 2015, an estimated $119K.
Weiss Multi-Strategy Advisers first reported a position in Novavax in Q3 2013 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Novavax position peaked at $295K in Q1 2014.
167 funds tracked by Wall St. Rank held Novavax as of Q1 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2015, filed 15 May 2015.